In our group, the analysis of the data demonstrated that age, tumor size, lymph node status, basal cell markers, histological grade, expression of VEGF, HIF-1α, and BRCA1, clinical stage, and pathological stage were not associated with disease progression (p > 0.05). Here, BRCA1 is linked to neoplasm.